Back to Screener

Healthcare

Halozyme Therapeutics, Inc.(HALO)

Live Price

Offline

$74.96

+3.19% today

1Y Change

+43.57%

Window

Jun 27, 2025 โ†’ Jun 26, 2026

Market Cap
$7.54B
Revenue Growth
+37.6%
EPS Growth
-24.6%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 27, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Halozyme Therapeutics, Inc. (HALO) is a Healthcare stock with a market cap of $7.54B and listed on NASDAQ. The stock last traded around $74.96 and up 43.6% across the available one-year price window (Jun 27, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +37.6%, EPS growth of -24.6%, a dividend yield of 0.0%. What stands out right now is revenue +37.6%, EPS -24.6%, free cash flow +37.6% with operating margin 58.4% and ROIC 23.6%. Valuation sits in the middle of the pack at P/E 23.6 and price/sales 5.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HALO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

HALO vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

HALO

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

HALO Max Drawdown

-24.13%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for HALO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est 1.52
โ€”
โ€”
Est 358745.2B
โ€”
May 5
โ€”
Feb 17, 26
โœ—
-0.24
Est 2.15
-111.2%
451767.0B
Est 435705.6B
+3.7%
Feb 17
โ€”
Nov 3, 25
โœ“
1.72
Est 1.63
+5.5%
354264.0B
Est 446507.8B
-20.7%
Nov 3
โ€”
Aug 5, 25
โœ“
1.54
Est 1.23
+25.2%
325719.0B
Est 330780.7B
-1.5%
Aug 5
โ€”
May 6, 25
โœ“
1.11
Est 0.95
+16.8%
264861.0B
Est 280972.8B
-5.7%
May 6
โ€”
Feb 18, 25
โœ“
1.26
Est 1.17
+7.7%
298008.0B
Est 285741.4B
+4.3%
Feb 18
โ€”
Oct 31, 24
โœ“
1.27
Est 0.98
+29.6%
290084.0B
Est 292825.1B
-0.9%
Oct 31
โ€”
Aug 6, 24
โœ“
0.91
Est 0.76
+19.7%
231353.0B
Est 208940.0B
+10.7%
Aug 6
โ€”
May 7, 24
โœ“
0.79
Est 0.70
+12.9%
195879.0B
Est 199780.0B
-1.9%
May 7
โ€”
Feb 20, 24
โœ—
0.82
Est 0.83
-1.2%
230039.0B
Est 231140.0B
-0.5%
Feb 20
โ€”
Nov 6, 23
โœ“
0.75
Est 0.71
+5.6%
216033.0B
Est 222630.0B
-3.0%
Nov 6
โ€”
Aug 8, 23
โœ“
0.74
Est 0.63
+17.5%
221038.0B
Est 199950.0B
+10.6%
Aug 8
โ€”
May 9, 23
โœ—
0.47
Est 0.48
-2.1%
162143.0B
Est 175510.0B
-7.6%
May 9
โ€”
Feb 21, 23
โœ“
0.48
Est 0.47
+2.1%
181496.0B
Est 192054.5B
-5.5%
Feb 21
โ€”
Nov 8, 22
โœ“
0.74
Est 0.52
+42.3%
208976.0B
Est 191170.9B
+9.3%
Nov 8
โ€”
Aug 9, 22
โœ“
0.53
Est 0.50
+6.0%
152365.0B
Est 138626.8B
+9.9%
Aug 9
โ€”
May 10, 22
โœ—
0.47
Est 0.49
-4.1%
117279.0B
Est 128253.4B
-8.6%
May 10
โ€”
Feb 22, 22
โœ“
0.42
Est 0.41
+2.4%
102003.0B
Est 101538.1B
+0.5%
Feb 22
โ€”
Nov 2, 21
โœ“
0.55
Est 0.42
+30.9%
115830.0B
Est 106960.0B
+8.3%
Nov 2
โ€”
Aug 9, 21
โœ“
0.62
Est 0.41
+51.2%
136455.0B
Est 104040.0B
+31.2%
Aug 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar